Frontlight ResearchEarly access
Macular degeneration trials in Estonia
2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Where
- Tallinn, Tartu
- Age
- 50 years and over
- People
- 960 worldwide
- Run by
- EyeBiotech Ltd.
See details and how to joinNCT07440225 - Phase 2/3Taking peopleA randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)
- Where
- Tallinn, Tartu Linn
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Eyebiotech Limited
See details and how to join2025-524575-22-00